Glucocorticoids remain the frontline treatment for inflammatory disorders, yet represent a
double-edged sword with beneficial therapeutic actions alongside adverse effects, mainly in …

Radiotherapy remains one of the corner stones in the treatment of various malignancies and
often leads to an improvement in overall survival. Nonetheless, pre-clinical evidence …

Objective: Summarizing the evidence on the effects of pre-and postoperative exercise and
psychosocial rehabilitation interventions on patient-reported outcomes (PROs) and physical …

Molecular stratification can improve the management of advanced cancers, but requires
relevant tumor samples. Metastatic urothelial carcinoma (mUC) is poised to benefit given a …

Preclinical data indicate that radiotherapy works synergistically with pembrolizumab, but the
effect and toxicity of this combination may depend on radiotherapy timing. We conducted a …

Importance Although immune checkpoint inhibitors (ICIs) targeting programmed cell death 1
(PD-1) and PD-1 ligand 1 have improved the outcome for many cancer types, the majority of …

Background Acute and late toxicity after intensity‐modulated radiotherapy (IMRT) for head
and neck cancer (HNC) impacts on patient quality of life; yet, very late toxicity data remain …

Background Combining radiotherapy (RT) with immuno-oncology (IO) therapy (IORT) may
enhance IO-induced antitumor response. Quantitative imaging biomarkers can be used to …

Purpose Nivolumab improves survival in patients with metastatic melanoma. Unfortunately,
most patients do not respond to this treatment. Preclinical data indicate that radiation therapy …

Simple Summary Although the SARS-CoV-2 pandemic is likely to have created or
aggravated mental health symptoms in cancer patients, high-quality longitudinal data on this …